These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 9892774

  • 1. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease.
    Reguero JR, Cubero GI, Batalla A, Alvarez V, Hevia S, Cortina A, Coto E.
    Cardiology; 1998 Dec; 90(3):231-5. PubMed ID: 9892774
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.
    Wang XL, Liu SX, McCredie RM, Wilcken DE.
    J Clin Invest; 1996 Jul 15; 98(2):372-7. PubMed ID: 8755647
    [Abstract] [Full Text] [Related]

  • 4. Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease.
    Zou Y, Hu D, Yang X, Jia X, Wang L, Cui L, Liu X, Gao M, Wei Y, Xu Z.
    Chin Med J (Engl); 2003 May 15; 116(5):665-8. PubMed ID: 12875674
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels.
    Wang XL, Badenhop R, Humphrey KE, Wilcken DE.
    Genet Epidemiol; 1996 May 15; 13(1):1-10. PubMed ID: 8647374
    [Abstract] [Full Text] [Related]

  • 7. The MspI restriction fragment length polymorphism 3' to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Civeira F, Genest J, Pocovi M, Salem DN, Herbert PN, Wilson PW, Schaefer EJ, Ordovas JM.
    Atherosclerosis; 1992 Feb 15; 92(2-3):165-76. PubMed ID: 1352975
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L, Raimondo G, Di Benedetto A, Romano G, Porcellini A, Campo S, Corica F, Riccardi G, Squadrito G, Cucinotta D.
    Acta Diabetol; 1995 Dec 15; 32(4):251-6. PubMed ID: 8750764
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: a pilot study in a north Indian population.
    Dawar R, Gurtoo A, Singh R.
    Am J Clin Pathol; 2010 Aug 15; 134(2):249-55. PubMed ID: 20660328
    [Abstract] [Full Text] [Related]

  • 11. Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels.
    Larson IA, Ordovas JM, Barnard JR, Hoffmann MM, Feussner G, Lamon-Fava S, Schaefer EJ.
    Clin Genet; 2002 Mar 15; 61(3):176-84. PubMed ID: 12000358
    [Abstract] [Full Text] [Related]

  • 12. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism.
    Espino-Montoro A, Barrios-Artillo M, López-Chozas JM, Cayuela A, Stiefel P, Villar J.
    Nutr Metab Cardiovasc Dis; 2003 Aug 15; 13(4):194-201. PubMed ID: 14650351
    [Abstract] [Full Text] [Related]

  • 13. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.
    Wu H, Huang Q, Yu Z, Wu H, Zhong Z.
    Lipids Health Dis; 2020 Sep 05; 19(1):202. PubMed ID: 32891149
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E gene polymorphisms and risk for coronary artery disease in Chinese Xinjiang Uygur and Han population.
    Yang SL, He BX, Liu HL, He ZY, Zhang H, Luo JP, Hong XF, Zou YC.
    Chin Med Sci J; 2004 Jun 05; 19(2):150-4. PubMed ID: 15250257
    [Abstract] [Full Text] [Related]

  • 15. Polymorphisms in the apolipoprotein E gene regulatory region in relation to coronary heart disease and their effect on plasma apolipoprotein E.
    Corbo RM, Scacchi R, Vilardo T, Ruggeri M.
    Clin Chem Lab Med; 2001 Jan 05; 39(1):2-6. PubMed ID: 11256794
    [Abstract] [Full Text] [Related]

  • 16. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D, Zorc M, Peterlin B.
    Folia Biol (Praha); 2000 Jan 05; 46(5):181-5. PubMed ID: 11055796
    [Abstract] [Full Text] [Related]

  • 17. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B, Candlish JK, Saha N, Heng CK, Soemantri AG, Tay JS.
    Genet Epidemiol; 1994 Jan 05; 11(1):19-27. PubMed ID: 8013886
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S, Lehtimäki T, Sisto T, Salenius JP, Nikkilä M, Jokela H, Koivula T, Ebeling F, Ehnholm C.
    Atherosclerosis; 1995 Apr 07; 114(1):83-91. PubMed ID: 7605379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.